1. Home
  2. IZEA vs SLGL Comparison

IZEA vs SLGL Comparison

Compare IZEA & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IZEA
  • SLGL
  • Stock Information
  • Founded
  • IZEA 2006
  • SLGL 1997
  • Country
  • IZEA United States
  • SLGL Israel
  • Employees
  • IZEA N/A
  • SLGL N/A
  • Industry
  • IZEA Advertising
  • SLGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • IZEA Consumer Discretionary
  • SLGL Health Care
  • Exchange
  • IZEA Nasdaq
  • SLGL Nasdaq
  • Market Cap
  • IZEA 60.8M
  • SLGL 69.1M
  • IPO Year
  • IZEA N/A
  • SLGL 2018
  • Fundamental
  • Price
  • IZEA $3.55
  • SLGL $24.35
  • Analyst Decision
  • IZEA
  • SLGL
  • Analyst Count
  • IZEA 0
  • SLGL 0
  • Target Price
  • IZEA N/A
  • SLGL N/A
  • AVG Volume (30 Days)
  • IZEA 93.3K
  • SLGL 32.4K
  • Earning Date
  • IZEA 11-13-2025
  • SLGL 11-14-2025
  • Dividend Yield
  • IZEA N/A
  • SLGL N/A
  • EPS Growth
  • IZEA N/A
  • SLGL N/A
  • EPS
  • IZEA N/A
  • SLGL N/A
  • Revenue
  • IZEA $36,935,906.00
  • SLGL $23,931,000.00
  • Revenue This Year
  • IZEA $11.15
  • SLGL N/A
  • Revenue Next Year
  • IZEA $17.64
  • SLGL $31.17
  • P/E Ratio
  • IZEA N/A
  • SLGL N/A
  • Revenue Growth
  • IZEA 12.49
  • SLGL 264.86
  • 52 Week Low
  • IZEA $1.68
  • SLGL $4.01
  • 52 Week High
  • IZEA $4.39
  • SLGL $30.00
  • Technical
  • Relative Strength Index (RSI)
  • IZEA 43.72
  • SLGL 59.60
  • Support Level
  • IZEA $3.51
  • SLGL $23.13
  • Resistance Level
  • IZEA $3.90
  • SLGL $24.85
  • Average True Range (ATR)
  • IZEA 0.31
  • SLGL 2.20
  • MACD
  • IZEA -0.05
  • SLGL -0.53
  • Stochastic Oscillator
  • IZEA 17.86
  • SLGL 37.22

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: